Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				Ten Year NIOSH Program Review						Print
																Related Pages
										On This Page
			Quality of ScienceTimeliness of Task AccomplishmentsSpecial Exposure CohortDose ReconstructionsQuality of ServicePublic Comments
		
2010 marked the tenth anniversary of the passage of EEOICPA. Under EEOICPA, the President delegated to the Secretary of HHS the tasks of performing radiation dose reconstructions and evaluating petitions to add classes of employees to the SEC. As of December 31, 2010, NIOSH had completed 27,832 radiation dose reconstructions and had received for 182 SEC petitions to be considered for adding classes of employees to the SEC.
Given the passage of 10 years and the considerable amount of work that has been accomplished by NIOSH in support of EEOICPA, the Director of NIOSH commissioned a ten year retrospective review of NIOSH’s efforts.
The ten year review was conducted by NIOSH employees and CDC/NIOSH contractors who were familiar with NIOSH’s activities under EEOICPA, but not directly involved in the supervision of those activities. Draft reports were developed and public comments were received on the draft reports. Since that time, the five reports have been finalized and consideration given to the public comments received.
More information on the review such as Federal Register Notices, materials previously under consideration, and public comments on the review can be found on the NIOSH Docket 194.
Recommendations
The document below contains a list of the overall recommendations from the final reports on the five topic areas under consideration for the ten year review:
Recommendations Excerpted from the Five Review Reports [339 KB (14 pages)]
Action Items
The document below contains a list of the action items NIOSH is currently working on in response to the ten year review recommendations:
Draft: NIOSH Dose Reconstruction Program Ten Year Review – NIOSH Follow Up Action Items Concerning Dose Reconstruction [100 KB (5 pages)]
Quality of Science Review
**Final Review Report on the Quality of Science**
Ten Year Report: Quality of Science [652 KB (79 pages)] 2011
Issues and Action ItemsIssues related to documentation
Action 1: DCAS will explore the use of tools (such as data base management tools) to minimize the possibility of inconsistencies between NIOSH Procedures.
Action 2: DCAS will develop a list of products it will submit to external peer review, consistent with the recommendation to make broader use of peer review within the program.
Issues related to modification of the procedures data base
Action 1: DCAS will explore modifications of the Procedures database that would include information on the resolution of comments from all sources. DCAS will develop an estimate of the cost to implement such modification, and prioritize such an implementation relative to the implementation of other recommendations that result from the Program Review.
Issues related to indirect exposure assessments
Action 1: DCAS will perform a trial run on one or two sites that will allow for the validation of the exposure assessment methodology used by DCAS in a completed program action. The Savannah River Site will be used for one of these trial runs.
Issues related to “better” characterization of claimant favorability.
Action 1: DCAS will consider how best to undertake such a task and report back to NIOSH Leadership.
Issues related to review of OTIB 0020
Action 1: DCAS will review as appropriate modify that OTIB.
Issues related surrogate data
Action 1: DCAS will undertake a detailed review of the EPA methodology. Consistent with efforts to diversify the accomplishment of program tasks. DCAS will invite “other than Health Physicists” to join in the performance of such a review.
Timeliness of Task Accomplishments Review
**Final Review Report on the Timeliness of Task Accomplishments**
Ten Year Report: Timeliness of Task Accomplishments [652 KB (79 pages)] 2011
Issues and Action ItemsIssues related to higher priority to returns
Action 1: DCAS will continue its current efforts to give higher priority to returns.
Action 2: DCAS will share with the Program Review team its current targets for processing returns.
Issues related to aggressive time limits for dose reconstructions
Action 1: DCAS will prepare cost estimates for the realization of more aggressive time limits for dose reconstructions and prioritize such efforts relative to the implementation of other Program Review recommendations.
Issues related to aggressive time limits for the completion of the review of SEC petitions
Action 1: The DFO and the DCAS Director will discuss this issue with the Board Chair and explore strategies for realizing this recommendation while working in conjunction with the Board.
Action 2: DCAS will prepare a white paper that lays out a plan for realizing this recommendation. The white paper will be based upon NIOSH and the Board limiting their initial efforts in review of an SEC Petition to only those issues raised by the Petition. Should other issues arise that are worthy of consideration, these issues would be addressed through other means, such as 83.14 petitions.

Special Exposure Cohort Review
**Final Review Report on the Special Exposure Cohort**
Ten Year Report: Special Exposure Cohort [652 KB (79 pages)] 2011
Issues and Action ItemsIssues related to separating “policy” issues from “science” issues
Action 1: DCAS will prepare a draft of a Petition Evaluation Report that includes a section that identifies all important “decision points,” and provides the rational for the path chosen by DCAS in its report. NIOSH Leadership will review such a draft evaluation report to identify the “nature” of the decisions made. If those decision points are determined to be “policy” decision points, the appropriate level in the organization as to where such decisions should be made will be identified.
Issues related to the definition of sufficient accuracy
Action 1: DCAS will develop a series of paragraphs that begin to define, to the degree possible, aspects of a definition of “sufficient accuracy.”
Action 2: NIOSH Leadership will review such paragraphs and provide feedback to DCAS.
Issues related to a possible health physics bias
Action 1: In drafting the paragraphs related to the definition of sufficient accuracy, DCAS will consult with “other than Health Physicists.” In this way it can start to explore the contributions that can be made to the program by other disciplines.

Dose Reconstruction Review
**Final Review Report on Dose Reconstruction**
Ten Year Report: Dose Reconstruction [652 KB (79 pages)] 2011
Issues and Action ItemsIssues related to QA/QC
Action 1: DCAS/ORAU will provide documentation of current in place QA/QC efforts, including QA/QC plans and the results of several years of use of such plans.
Action 2: DCAS will work with the Subcommittee on Dose Reconstruction as they explore DCAS QA/QC efforts.
Action 3: DCAS will provide an answer to the question, “If the Board’s review has found an “error” in DCAS’s efforts, why was that error not found by the internal DCAS/ORAU QA/QC review?”
Issues related to use of efficiency measures
Action 1: DCAS will review current communications to those filling claims, and where necessary make improvements in such communications.
Action 2: DCAS will perform a cost benefit analysis of the elimination of the use of overestimating dose reconstructions.
Action 3: DCAS will prioritize the elimination of overestimating dose reconstructions relative to their implementation of other Program Review recommendations.

Quality of Service Review
**Final Review Report**
Ten Year Report: Quality of Service [652 KB (79 pages)] 2011
Issues and Action ItemsIssues related to using customer supplied information
Action 1: DCAS will review current communications vehicles and where appropriate will make improvements in such vehicles.
Issues related to understandability and quality of information
Action 1: DCAS will continue ongoing efforts to evaluate and improve the understandability and quality of DCAS communication vehicles.
Issues related to access to information
Action 1: DFO and staff will continue efforts to see that Board and Work Group work products are posted on the website as soon as practical.
Issues related to perceived burden on claimants and petitioners
Action 1: DCAS will consider its current communications strategies as they might present perceived burdens to claimants and petitioners, particularly in light of the real burden felt by those individuals through their interactions with the DOL.
**NIOSH Progress on Issues and Action Items from the Final Report**
Quality of Service Review, Issue 2, Action 1 [72 KB (1 pages)]January 25, 2013
Quality of Service Review, Issue 3, Action 1 [72 KB (1 pages)]January 25, 2013
Quality of Service Review, Issue 4, Action 1 [118 KB (3 pages)]January 25, 2013

Public Comments on the 10 Year Review
Federal Register Notices, final reports, materials under consideration, and public comments on the review can be found on the NIOSH Public Docket Website, Radiation Dose Reconstruction Review page.
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue